PROVIDENCE THERAPEUTICS
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat advanced ovarian cancer. The company's vaccine identifies tumor mutations and elicits an immune response against the tumor cells, enabling users to treat themselves and live life to the fullest. It aims to provide safe and effective medicines for people suffering from diseases with unmet medical needs. Scott Leary, Eric Marcusson, and Bradley Sorenson established the company in Toronto, Ontario in 2015.
PROVIDENCE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2015-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.providencetherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Bone-Rad Therapeutics
Bone-Rad Therapeutics is a Delaware corporation whose objective is to develop and market brachytherapy bone cement to treat tumors in bone.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Edifice Health
Edifice Health is a immunological health and personalized nutrition company offering a novel metric of inflammatory health.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Providence Therapeutics
Official Site Inspections
http://www.providencetherapeutics.com Semrush global rank: 2.19 M Semrush visits lastest month: 9.01 K
- Host name: server81.calgarywebpagehosting.com
- IP address: 144.217.84.119
- Location: Beauharnois Canada
- Latitude: 45.3161
- Longitude: -73.8736
- Timezone: America/Toronto
- Postal: J6N
More informations about "Providence Therapeutics"
About - Providence Therapeutics
Each member brings a deep understanding and extensive experience, which helps our organization stay ahead in mRNA technology, including drug development and vaccine production. Good communication and teamwork are …See details»
Meet the Team - Providence Therapeutics
Each member brings a deep understanding and extensive experience, which helps our organization stay ahead in mRNA technology, including drug development and vaccine …See details»
Providence Therapeutics - BioTalent Canada
Providence Therapeutics is a private Canadian biotechnology company that specializes in messenger RNA (mRNA) vaccine therapies. We hold deep expertise in the science of mRNA with operations located in Calgary, Alberta …See details»
Providence Therapeutics - Crunchbase Company …
Contact Email [email protected] Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat advanced ovarian cancer. The company's vaccine identifies …See details»
Providence and Ontario Institute for Cancer Research …
May 23, 2024 Providence has a robust pipeline consisting of preclinical and clinical oncology, infectious diseases, and animal health programs. These programs have been developed internally and in collaboration with academic …See details»
Providence Therapeutics - LinkedIn
Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is …See details»
Providence Therapeutics Welcomes Funding from NGen to
Jan 21, 2021 For more information, please visit www.providencetherapeutics.com. About NGen - Next Generation Manufacturing Canada NGen is the industry-led not-for-profit organization …See details»
CEO of Calgary's Providence Therapeutics again seeks …
Apr 20, 2021 The head of a Calgary-based company in the midst of clinical trials for a COVID-19 vaccine made another pitch for federal funding Monday. Brad Sorenson, the CEO of Providence Therapeutics ...See details»
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as …
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Providence Therapeutics Holdings Inc. ("Providence"), a biopharmaceutical company developing messenger RNA (mRNA) …See details»
History of Providence - Providence Therapeutics
Providence Therapeutics exited the pandemic with much more than a COVID-19 vaccine; we came out with a full-fledged mRNA medicines ecosystem consisting of a proven mRNA platform, a next-generation LNP platform, and a robust …See details»
Providence Therapeutics Announces New Board Appointment - PR …
CALGARY, AB, Oct. 28, 2021 /PRNewswire/ - ("Providence"), a leading clinical-stage messenger RNA (mRNA) biotechnology company currently focused on a COVID19 vaccine and vaccine …See details»
COVID-19 vaccine maker Providence says it's leaving Canada
Apr 30, 2021 The head of a homegrown company behind a promising COVID-19 vaccine says he's ready to pull his company out of Canada and take its product elsewhere after calls for …See details»
Providence Therapeutics Company Profile 2024: Valuation, …
Providence Therapeutics General Information Description. Operator of a biotechnology company intended to create messenger RNA (mRNA) vaccine therapies. The company focuses on …See details»
Providence Therapeutics announces first subject has been
Jan 26, 2021 For more information, please visit ProvidenceTherapeutics.com. SOURCE Providence Therapeutics Media Contact: Andrea Chrysanthou, Global Public Affairs, [email …See details»
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as …
While there, he also directed the development of new computational algorithms to address specific research and business needs to the GRC, as well as the clinical organization. …See details»
Providence Therapeutics Announces New mRNA Rabies Vaccine …
Dec 15, 2022 Novel rabies vaccine candidate developed with Providence’s mRNA platform further validates the technology Providence continues to expand its mRNA platform to target …See details»
Providence Therapeutics Announces New mRNA Rabies Vaccine
Dec 15, 2022 For more information, please visit providencetherapeutics.com. Forward-Looking Statements. ... 1 World Health Organization. (November 2022). Rabies. World Health …See details»
Providence Therapeutics Presents Phase 2 Data on its mRNA …
Nov 28, 2022 [email protected] 403-265-3765. Media Contact: Veronica Eames LifeSci Communications, LLC [email protected] 646-970-4682. View …See details»
Press Releases - Providence Therapeutics
Feb 1, 2023 Check out the latest press releases and updates regarding Providence Therapeutics, the Canadian biotechnology company specializing in mRNA vaccine therapies.See details»